ERRFI1 overexpression has been shown to reduce proliferation in GBM cells by binding EGFR to Syntaxin-8 and targeting internalized EGFR to late endosomes for degradation, while knockdown of ERRFI1 expression resulted in increased tumor invasion [68,79,93]. This evidence concerns the gene EGFR and neoplasm.